Target intelligence / Profile preview

Terminal sialic acid residues (Sia)

Target
Sia
Molecular classification
Carbohydrate, Glycan, Monosaccharide
01

Overview

Terminal sialic acid residues are nine-carbon acidic monosaccharides typically found at the outermost positions of glycan chains on the surface of host cell glycoproteins and glycolipids. These residues are essential for various biological processes, including cell-cell recognition, signal transduction, and the regulation of the immune system by acting as self markers that prevent autoimmune responses (Varki, 2008). However, they are also frequently utilized as attachment receptors by a wide range of pathogens, most notably the influenza virus, which uses its hemagglutinin protein to bind to specific sialic acid linkages (Schauer, 2009). In cancer, the upregulation of terminal sialic acids, or hypersialylation, facilitates tumor progression by promoting metastasis and allowing the tumor to evade immune detection through interactions with Siglec receptors on leukocytes (Bull et al., 2014). Therapeutic approaches include the use of inhaled recombinant sialidases, such as DAS181, which enzymatically remove these residues to prevent viral entry, as well as neuraminidase inhibitors that block the viral enzyme from cleaving these residues during the budding of new virions (Moss et al., 2012).

Other names
N-acetylneuraminic acidNeu5AcSialic acidsSialosidesGlycan-terminal sialic acidN-acetyl-neuraminate
02

Mechanism of action

Enzymatic cleavage of terminal sialic acid residues from host cell surfaces to prevent viral attachment; inhibition of viral neuraminidase to prevent the cleavage of sialic acid and release of viral progeny.

03

Biological functions

Cell-cell recognitionImmune system regulationPathogen attachmentSignal transductionCellular adhesion
04

Disease associations

InfectionInfluenzaCancerInflammationBacterial infection
05

Safety considerations

Disruption of host physiological glycan signalingPotential for mucosal irritation in respiratory deliveryImmunogenicity of exogenous sialidase enzymesPotential for transient inflammation due to loss of self-recognition markers
06

Interacting drugs

DAS181 (Fludase)

4 more in the full profile.

07

Biomarkers

Sialyl-Lewis X (sLeX)Total serum sialic acid (TSA)Neu5Ac concentrationSiglec-binding glycan profiles

Beyond the preview

Go deeper on Terminal sialic acid residues (Sia).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Terminal sialic acid residues (Sia).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call